• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER Back to Search Results
Lot Number 0033594112
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226); Cardiac Perforation (2513)
Event Date 04/03/2024
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that during a cardiac ablation procedure to treat paroxysmal atrial fibrillation using a farawave pulsed field ablation catheter the patient experienced a drop in blood pressure, pericardial effusion, cardiac tamponade, and perforation of the left atrial appendage.Transseptal access was achieved using a versacross connect system with the faradrive sheath, then a non-boston scientific multi-spline mapping catheter was inserted to collect left atrial geometry.The farawave catheter with a boston scientific distributed guidewire was inserted and ablation of the left pulmonary veins was performed without issue.However, after this a drop in blood pressure was detected.An intracardiac echo was performed and a pericardial effusion was noticed immediately.Instant methods were employed to relieve the blood drainage into the pericardial space, including pericardiocentesis where several hundred cc of blood was collected.Once the effusion was greatly reduced, the patient was transferred to cardiac surgery, where a sternotomy was performed and two small holes in the left atrial appendage were detected.It is unknown whether this occurred as a result of the transseptal puncture, multi-spline mapping catheter manipulation, or farawave catheter/wire manipulation.The procedure was not able to be completed due to the patient complications.The patient was held afterwards for observation, but is expected to recover.The device is not expected to be returned for analysis due to disposal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM
Type of Device
CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key19198753
MDR Text Key341236637
Report Number2124215-2024-24710
Device Sequence Number1
Product Code QZI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number0033594112
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/03/2024
Initial Date FDA Received04/26/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2024
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient SexMale
Patient RaceWhite
-
-